Insider Trading Alert - IBM, HOG And CME Traded By Insiders

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

Yesterday, Feb. 12, 2014, 128 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $79.73 to $121,490,730.00.

Highlighted Stocks Traded by Insiders:

International Business Machines (IBM) - FREE Research Report

Rhodin Michael D. who is Senior Vice President at International Business Machines sold 4,500 shares at $180.23 on Feb. 12, 2014. Following this transaction, the Senior Vice President owned 15,917 shares meaning that the stake was reduced by 22.04% with the 4,500-share transaction.

The shares most recently traded at $179.88, down $0.35, or 0.2% since the insider transaction. Historical insider transactions for International Business Machines go as follows:

  • 4-Week # shares sold: 6,348
  • 12-Week # shares bought: 1,000
  • 12-Week # shares sold: 6,348
  • 24-Week # shares bought: 1,000
  • 24-Week # shares sold: 32,632

The average volume for International Business Machines has been 5.2 million shares per day over the past 30 days. International Business Machines has a market cap of $195.1 billion and is part of the technology sector and computer software & services industry. Shares are down 3.91% year-to-date as of the close of trading on Wednesday.

International Business Machines Corporation provides information technology (IT) products and services worldwide. The stock currently has a dividend yield of 2.11%. The company has a P/E ratio of 11.0. Currently there are 4 analysts that rate International Business Machines a buy, no analysts rate it a sell, and 12 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IBM - FREE

TheStreet Quant Ratings rates International Business Machines as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, increase in net income, good cash flow from operations and notable return on equity. We feel these strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full International Business Machines Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

Harley-Davidson (HOG) - FREE Research Report

Bischmann Joanne M who is Vice President, Communications at Harley-Davidson sold 371 shares at $65.13 on Feb. 12, 2014. Following this transaction, the Vice President, Communications owned 1,272 shares meaning that the stake was reduced by 22.58% with the 371-share transaction.

The shares most recently traded at $64.62, down $0.51, or 0.79% since the insider transaction. Historical insider transactions for Harley-Davidson go as follows:

  • 4-Week # shares sold: 14,225
  • 12-Week # shares sold: 14,225
  • 24-Week # shares sold: 14,225

The average volume for Harley-Davidson has been 1.2 million shares per day over the past 30 days. Harley-Davidson has a market cap of $14.3 billion and is part of the consumer goods sector and automotive industry. Shares are down 5.88% year-to-date as of the close of trading on Wednesday.

Harley-Davidson, Inc. manufactures heavyweight cruiser and touring motorcycles. The company operates through two segments: the Motorcycles segment and the Financial Services segment. The stock currently has a dividend yield of 1.7%. The company has a P/E ratio of 19.7. Currently there are 11 analysts that rate Harley-Davidson a buy, no analysts rate it a sell, and 3 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on HOG - FREE

TheStreet Quant Ratings rates Harley-Davidson as a buy. The company's strengths can be seen in multiple areas, such as its growth in earnings per share, revenue growth, good cash flow from operations, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full Harley-Davidson Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

CME Group (CME) - FREE Research Report

Odom C C II who is Director at CME Group sold 2,000 shares at $76.04 on Feb. 12, 2014. Following this transaction, the Director owned 4,003 shares meaning that the stake was reduced by 33.32% with the 2,000-share transaction.

The shares most recently traded at $76.40, up $0.36, or 0.48% since the insider transaction. Historical insider transactions for CME Group go as follows:

  • 4-Week # shares sold: 2,120
  • 12-Week # shares bought: 350
  • 12-Week # shares sold: 6,636
  • 24-Week # shares bought: 350
  • 24-Week # shares sold: 12,755

The average volume for CME Group has been 2.1 million shares per day over the past 30 days. CME Group has a market cap of $25.7 billion and is part of the financial sector and financial services industry. Shares are down 2.12% year-to-date as of the close of trading on Wednesday.

CME Group Inc. operates the CME, CBOT, NYMEX COMEX, and KCBT futures exchanges worldwide. It operates CBOT exchange, a marketplace for trading agricultural and the U.S. The stock currently has a dividend yield of 2.46%. The company has a P/E ratio of 26.2. Currently there are 6 analysts that rate CME Group a buy, 1 analyst rates it a sell, and 5 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on CME - FREE

TheStreet Quant Ratings rates CME Group as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, growth in earnings per share, revenue growth, reasonable valuation levels and expanding profit margins. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook. Get the full CME Group Ratings Report from TheStreet Quant Ratings now.

STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12 months. Learn more.

null

More from Markets

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Inside Carnival's Mind Blowing New Horizon Cruise Ship (Video)

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Jim Cramer: The 10-Year Yield Could Go to 2.75%

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Oil Slumps, Gas Spikes Ahead of Holiday Weekend; Assessing the Chipmakers--ICYMI

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Week Ahead: Wall Street Looks to Jobs Report as North Korea Meeting Less Certain

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%

Dow and S&P 500 Decline, Energy Shares Fall as U.S. Crude Oil Slides 4%